Vitaspring Biomedical (VSBC) EBITDA (2017 - 2026)
Vitaspring Biomedical's EBITDA was -$73,355 in fiscal Q1 2027 (quarter ended Apr 30, 2026), compared with -$66,658 a year earlier.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) EBITDA (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vitaspring Biomedical's EBITDA was -$382,151 through Apr 30, 2026; for FY2026 (ended Jan 31, 2026), it was -$375,454.
- In earlier fiscal years, EBITDA was -$669,957 in FY2025, -$1.1 million in FY2024, -$4.16 million in FY2023 and $1.14 million in FY2022.
- Quarterly EBITDA has moved between -$4.16 million (fiscal Q4 2023) and $1.42 million (fiscal Q4 2022) over five years.
- Per Business Quant data, VSBC's EBITDA in the three fiscal quarters before Q1 2027 was -$78,975 (Q4 2026), -$133,244 (Q3 2026) and -$96,577 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Vitaspring Biomedical | 4.14 Mn | 4.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -73,355.00 |
| Jan 31, 2026 | -78,975.00 |
| Oct 31, 2025 | -133,244.00 |
| Jul 31, 2025 | -96,577.00 |
| Apr 30, 2025 | -66,658.00 |
| Jan 31, 2025 | -124,005.00 |
| Oct 31, 2024 | -115,438.00 |
| Jul 31, 2024 | -216,172.00 |
| Apr 30, 2024 | -214,342.00 |
| Jan 31, 2024 | -221,633.00 |
| Oct 31, 2023 | -231,214.00 |
| Jul 31, 2023 | -349,818.00 |
| Apr 30, 2023 | -300,835.00 |
| Jan 31, 2023 | -4.16 Mn |
| Oct 31, 2022 | -179,453.00 |
| Jul 31, 2022 | -170,746.00 |
| Apr 30, 2022 | 346,893.00 |
| Jan 31, 2022 | 1.42 Mn |
| Oct 31, 2021 | 141,218.00 |
| Jan 31, 2021 | -345,730.00 |
API Access
Vitaspring Biomedical EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();